Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), will present at IQPC’s “7th Annual Improving Solubility” Conference in Philadelphia.
CONFERENCE: IQPC 7th Annual Improving Solubility Conference February 26-28, 2013 Philadelphia, PAWHAT: Presentation: “Amorphous Solid Dispersions: Toward a Predictable Science”
- A new approach to make formulation a rigorous, predictable science
- A proposal for automation enabled by a physical chemistry foundation
- Agere’s progress to date toward the goal